Clonidine is a classically categorized α 2 -adrenoceptor (α 2 -AR) agonist that produces vascular contractions by stimulating arterial smooth muscle α 2 -ARs. However, clonidine inhibits α 1 -AR-mediated arterial contractions. Recently, it was suggested that repeated stimulation with clonidine induces desensitization of α 2 -ARs, thus inhibiting noradrenaline-induced smooth muscle contractions. In the present study, we examined whether clonidine-mediated inhibition of α 1 -AR contractions involves interactions with α 2 -ARs in rat thoracic aortae. 1) Clonidine and guanfacine inhibited electrical field stimulation-induced contractions in a concentration-dependent, yohimbine-sensitive manner in isolated rat vas deferens preparations. 2) Clonidine almost completely suppressed phenylephrine-induced sustained contractions of rat thoracic aortae. 3) Clonidine competitively inhibited phenylephrine-induced contractions with a pA 2 value of 6.77 at concentrations between 10 −7 and 10 −6 M.
Introduction
Clonidine is classically classified as a selective α 2 -adrenoceptor (α 2 -AR) agonist [1] . Clonidine has been used clinically to treat high blood pressure, particularly in severe cases in which other fundamental antihypertensive drugs such as calcium antagonists do not result in improved symptoms. In addition, clonidine is used as a pre-anesthetic medication for various surgeries. Underlying mechanisms of clonidine-induced hypotensive effects include reduction of efferent sympathetic nerve activities, attributable to clonidine-mediated stimulation of α 2 -ARs in central nerves (vasomotor centers in bulbar), though α 2 -ARs are also present peripherally [2] .
Clonidine was first regarded as a presynaptic α 2 -AR agonist that suppresses the release of noradrenaline (NA) from sympathetic nerve endings by stimulating presynaptic α 2 -ARs [3] [4] . More recently, it has been shown that clonidine also targets postsynaptic α 2 -ARs, and clonidine-induced vascular contractions are explained by the stimulation of vascular smooth muscle α 2 -ARs [5] [6] [7] . Further, experimental evidence suggests possible interactions between clonidine and α 1 -ARs, and it has been suggested that clonidine acts as a partial agonist for α 1 -ARs. In vascular smooth muscles, clonidine causes contractile effects by directly stimulating α 1 -ARs and competitive antagonistic effects against full agonists, including NA [5] [6] [8] . However, it is generally recognized that the effects of clonidine on α 1 -ARs are generated through different mechanisms than those on α 2 -ARs, and these effects are produced independently.
It has been suggested that α 1 -ARs cross-talk with other drug receptors such as bradykinin B 2 receptors, endothelin-1 (ET A ) receptors, and lysophosphatidic acid (LPA) receptors [9] . Although there are few studies examining possible crosstalk between α 2 -ARs and α 1 -ARs, it has been shown that NA-induced contractions decrease as a result of clonidine-induced desensitization of α 2 -ARs in testicular capsules [10] . Based on this background information, we hypothesized that clonidine inhibits α 1 -AR-mediated contractions by stimulating α 2 -ARs; clonidine-induced inhibition of α 1 -AR-mediated contractions results from stimulation of α 2 -ARs.
Clonidine strongly inhibits phenylephrine-induced contractions in isolated rat thoracic aorta smooth muscles; therefore, the present study was carried out to determine whether this is mediated through stimulation of α 2 -ARs.
Materials and Methods

Drugs and Chemicals
The following drugs were used: clonidine and phenylephrine (Sigma-Aldrich
Co., MO, USA); guanfacine (Enzo Life Sciences, NY, USA); NA and yohimbine (Wako Pure Chemical Industries, Osaka, Japan); prostaglandin F 2α (PGF 2α ) (Fuji Pharma Co., Ltd, Tokyo, Japan); acetylcholine (ACh) and tetrodotoxin (TTX) (Daiichi Sankyo, Tokyo, Japan). All other chemicals used in the present study were commercially available and of reagent grade.
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All drugs were prepared as an aqueous solution and diluted with distilled water.
Animals
Male 
Preparation of Rat Aortic Rings
Wistar rats were sacrificed by cervical dislocation, and a section of the thoracic aorta from between the aortic arch and the diaphragm was isolated and placed in 
Measurement of Tension Changes in Rat Aortae
The aortic rings were mounted using stainless steel hooks in 5-ml organ bath chambers (UC-5; UFER Medical Instrument, Kyoto, Japan) containing normal After this procedure, preparations without functional endothelium were left to equilibrate for at least 40 min.
Experimental Procedure
Aortic ring preparations were pre-contracted with phenylephrine (3 × 10 
Measurement of Tension Changes in Response to Nerve Electrical Field Stimulation (EFS) in Rat Vas Deferens
Wistar rats were sacrificed by cervical dislocation, and both right and left vas deferens were isolated. Each vas deferens was mounted between stimulating electrodes made of platinum using a cotton thread, with an optimal resting tension of 1.0 g; samples were maintained in a 20-ml organ bath containing normal 
Evaluation and Statistical Analysis
The relative relaxation of α 2 -AR agonists (clonidine and guanfacine) on sustained vascular contractions is expressed as percent relaxation; the tension level just before adding the agonists was considered 0% relaxation, and the basal tension level before applying vasoconstrictor stimulations (phenylephrine, PGF 2α , or high KCl) was considered 100% relaxation. To construct control concentration-response curves (CRCs) for phenylephrine, percent contractions were calculated by using the tension level before the cumulative application of phenylephrine as 0% and the maximum contraction obtained with application of high KCl (8 × 10 −2 M) as 100% for each preparation.
EC 50 and E max values were defined as the concentration required to produce a 50% response and maximal response induced by phenylephrine, respectively.
EC 50 values were converted to logarithmic values (pD 2 , −logEC 50 ) for statistical analysis. Competitive antagonistic potency is expressed as a pA 2 value determined from a Schild plot analysis of the results [11] .
The data are expressed as means ± S.E.M. or 95% confidence intervals (CIs); n refers to the number of experiments. Statistical analysis was performed with the unpaired student's t-test or one-way analysis of variance (one-way ANOVA)
followed by Dunnett's multiple comparison test using GraphPad Prism TM (version 7.00; GraphPad Software, San Diego, C.A., USA). A P value < 0.05 was considered significant in all cases. Figure 2 shows the effects of guanfacine on EFS-induced contractions in rat vas (Figure 3(A) ). The Emax and pD 2 values for clonidine were calculated as 97.9% ± 0.6% and 6.88 ± 0.08 (n = 4) (Figure 3(B) ). (Figure 4(B) ). The pA 2 value for clonidine was calculated as 6.77 (6.48 -7.32, n = 4) (Figure 4(B) ). In contrast, clonidine (10 −5 M) dramatically shifted the phenylephrine CRC to the right and strongly reduced the Emax value from 96.9% ± 1.2% to 39.8% ± 5.5% (n = 4 for each, P < 0.05).
Results
Inhibitory Effects of Clonidine on EFS-Induced Rat Vas Deferens Contractions and the Antagonistic Effects of Yohimbine vs. Clonidine
Inhibitory Effects of Guanfacine on EFS-Induced Vas Deferens Contractions and the Antagonistic Effects of Yohimbine vs. Guanfacine
Inhibitory Effects of Clonidine on Phenylephrine-Induced Contractions
Inhibitory Effects of Clonidine on PGF2α or 40 mM
KCl-Induced Contractions 
Effects of Yohimbine at High Concentrations on Clonidine-Associated Suppression of Phenylephrine-Induced Contractions
In this series of experiments, we used phenylephrine at 10 −6 M to obtain sustained there were no statistically significant differences between the two responses ( Figure 6(B) ). (Figure 3(B) ).
Effects of Guanfacine on Phenylephrine-Induced Contractions
Discussion
This finding suggests that the inhibitory effects of clonidine on phenylephrineinduced contractions cannot be entirely explained by its partial agonist action on α 1 -ARs, but that additional effects should be taken into account. Therefore, in the present study we continued to clarify other plausible factors contributing to the inhibitory effects of clonidine on phenylephrine-induced contractions in rat thoracic aortae.
We examined the effects of clonidine on phenylephrine CRCs and carried out Schild plot analyses. The inhibitory effects of clonidine at concentrations of 10 value was calculated to be 6.77 (Figure 4(B) ), which is consistent with a previously reported value (6.7) against α 1 -ARs (α 1B -ARs) [14] . Therefore, the inhi- The α 1B -AR and α 1D -AR subtypes primarily mediate arterial contractions induced by endogenous catecholamines, and chemically synthesized α 1 -AR agonists such as phenylephrine are primarily mediated by these α 1 -AR subtypes [15] [16]. Further, α 1B -ARs are reportedly desensitized by phosphorylation through cross-talk upon stimulation of other drug receptors with bradykinin, endothelin, transforming growth factor (TGF)-β, and LPA [9] . Among these drug receptors, the LPA receptor is classified as a Gi-protein-coupled receptor and induces desensitization of α 1B -ARs when phosphorylated through activation of phosphatidylinositol-3 kinase (PI3K) and protein kinase C (PKC) [9] . The α 2 -ARs expressed in rat aortic smooth muscle cells [17] are also Gi-protein coupled receptors and stimulation causes activation of PI3K and PKC [18] . Therefore, it is plausible that stimulation of α 2 -ARs with clonidine desensitizes α 1B -ARs through cross-talk between α 1B -ARs and α 2 -ARs. Based on these studies, we hypothesized that stimulation of α 2 -ARs with high concentrations of clonidine would induce desensitization of α 1B -ARs, consequently inhibiting phenylephrine-induced contractions in rat thoracic aortae.
To verify this hypothesis, we examined whether the inhibitory effects of high concentrations of clonidine on phenylephrine-induced contractions could be attenuated by inhibiting α 2 -ARs with yohimbine. Previously, we confirmed the stimulating effects of clonidine and guanfacine on α 2 -ARs and the inhibitory effects of yohimbine on α 2 -ARs using a rat vas deferens preparation. Finally, results of this study are clinically significant. Guanfacine is not used for hypertension in Japan, whereas clonidine is still employed as an antihypertensive drug-though it is not currently ranked as high as it has been in the past.
The clinical usefulness of clonidine is supported by the idea that it acts as an α 1 -AR competitive antagonist, whereas guanfacine does not, as shown in this study. Clonidine is still used as an α 2 -AR agonist in basic pharmacological studies; however, our study indicates that studies using relatively high concentrations of clonidine should be very carefully interpreted, as it inhibits α 1 -AR-mediated contractions at concentrations as low as 10 −7 M.
Conclusion
In this study, we examined whether clonidine-mediated inhibition of phenylephrine-induced contractions in rat thoracic aortae involves stimulation of α 2 -ARs and the subsequent inhibition of α 1 -ARs. However, no evidence was observed to indicate that stimulation of α 2 -ARs and subsequent interactions with α 1 -ARs mediates the inhibitory effects of clonidine on phenylephrine activity.
The inhibitory effects of clonidine on phenylephrine activity in rat aortae are unlikely to involve mediation of α 2 -ARs; however, these effects may be produced by direct inhibitory action on α 1 -ARs.
